These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8889372)

  • 21. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
    Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal consequences of arterial hypertension.
    Ruilope LM; Alcázar JM; Rodicio JL
    J Hypertens Suppl; 1992 Dec; 10(7):S85-90. PubMed ID: 1291661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can renal failure due to hypertension be prevented?
    Luke RG
    Hypertension; 1991 Sep; 18(3 Suppl):I139-42. PubMed ID: 1889853
    [No Abstract]   [Full Text] [Related]  

  • 24. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans.
    Lackland DT; Egan BM; Fan ZJ; Syddall HE
    J Clin Hypertens (Greenwich); 2001; 3(1):29-31. PubMed ID: 11416679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden.
    Siewert-Delle A; Ljungman S; Andersson OK; Wilhelmsen L
    Nephrol Dial Transplant; 1998 Dec; 13(12):3084-90. PubMed ID: 9870470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.
    Bae EH; Lim SY; Han KD; Oh TR; Choi HS; Kim CS; Ma SK; Kim SW
    Hypertension; 2019 Oct; 74(4):880-887. PubMed ID: 31422691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A call to action for more aggressive treatment of hypertension.
    Lenfant C; Roccella EJ
    J Hypertens Suppl; 1999 Feb; 17(1):S3-7. PubMed ID: 10340837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.
    Akwo EA; Robinson-Cohen C; Chung CP; Shah SC; Brown NJ; Ikizler TA; Wilson OD; Rowan BX; Shuey MM; Siew ED; Luther JM; Giri A; Hellwege JN; Velez Edwards DR; Roumie CL; Tao R; Tsao PS; Gaziano JM; Wilson PWF; O'Donnell CJ; Edwards TL; Kovesdy CP; Hung AM;
    Hypertension; 2021 Aug; 78(2):376-386. PubMed ID: 34148359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study.
    Bae EH; Lim SY; Kim B; Oh TR; Song SH; Suh SH; Choi HS; Yang EM; Kim CS; Ma SK; Han KD; Kim SW
    Hypertension; 2022 Aug; 79(8):1765-1776. PubMed ID: 35607989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic analysis of existing data to investigate hypertensive renal disease: an example from the Maryland End-Stage Renal Disease Registry.
    Brancati FL; Whelton PK; Whittle JC; Klag MJ
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):15-24. PubMed ID: 8465831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension as a risk factor for progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1994; 1():23-8. PubMed ID: 8205294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical documentation of end-stage renal disease due to hypertension.
    Schlessinger SD; Tankersley MR; Curtis JJ
    Am J Kidney Dis; 1994 May; 23(5):655-60. PubMed ID: 8172207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease.
    Iseki K; Kimura Y; Wakugami K; Okumura K; Muratani H; Ikemiya Y; Fukiyama K
    Hypertens Res; 2000 Mar; 23(2):143-9. PubMed ID: 10770261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.